The one thing I know about in life is change. I was 12 turning 13 when my father got sick and died. He had been diagnosed with an enlarged heart and was awaiting a heart transplant, so we travelled from Canada down to the United States for him to say goodbye to the rest of the family. It was our last night there, and he didn't make it. Read more
I joined dozens of people impacted by the rising cost of insulin in the USA in protest of those prices in front of Eli Lilly headquarters in Indianapolis, Indiana. Some had traveled many hours to join the protest, but one thing was made clear, we wanted to ensure that Eli Lilly heard our voices. We were passionate in our outcry for change and jointly understood that not saying anything is simply not an option.
Patients and those who support us will be demonstrating outside of Eli Lilly HQ in Indianapolis on Saturday, September 9th 2017. See the full post for more information and join us at https://www.facebook.com/groups/insulin4allAction/ if you can be there.
As insulin prices crept upward, I realized I needed to figure out more ways to increase my sensitivity and reduce the large load of insulin I had to pump into myself every day. It became more than a financial struggle; I was scared that synthetic insulin could become insufficient. Then what? So with my shallow pockets and fear for the future, I talked with my doctor about the type two medication, Metformin. Read more
In the wake of rising insulin prices in the United States and recent threats to public health safety nets like Medicaid, patients with type 1 diabetes are becoming increasingly more vulnerable. As a member of the T1D community and a rising second year Masters student at the Yale School of Public Health, Samantha Willner is hoping to shed light on the terrible sacrifices members of the T1D community in the U.S. have had to make in order to get the medicine they need to live. Read more
Sixteen organisations have signed an open letter to Dr. Tedros Adhanom Ghebreyesus, the incoming Director-General of the World Health Organization. The letter, penned by T1International, praises his attention to diabetes and requests that more focus is put on access to insulin and treatment for everyone living with diabetes around the world. Read more
I’ll start out by saying I consider myself lucky. Yes, you read that right. I consider myself fortunate to be in a country that’s consider to be progressive in technology and medical care. There are people in countries where electricity, consistent food supply and medications just don’t exist. For these people, the cost of chronic illness is too often immediate death. Read more
I have had times of desperation where I have used expired insulin, skipped some meals and diluted my insulin with water until I could afford to buy my next vial, but I am alive. I would like to suggest a few things to those who are possibly facing a future with no insurance... Read more
I write to you today as a young American with serious concerns for the future of health care in this country, namely with the GOP’s proposed American Health Care Act (AHCA). My health situation forces a more elevated interest in the current health care debate compared to many of my young peers because I have type 1 diabetes. My fellow diabetics and I (who number around 30 million in the US) rely on access to affordable prescriptions and health care for our very survival. When I say my concerns are serious, I am not exaggerating. Read more
When I was diagnosed with type 1 diabetes 38 years ago (March of 1979), my insulin cost my parents $10 a vial. Now, my co-pay for my insulin is $40 for the brand my insurance company wants me to use, or $60 for the brand that works better for me. If I choose to use my local pharmacy, and get my supplies for 3 months at a time, I have to pay the full amount of $120 for each Rx. If I use the insurance company and get everything via the mail, I only save $20. Read more